There’s nothing really funny about the patent debate on CRISPR-Cas9 gene editing. It’s been a contentious and expensive court battle, that has thankfully steered clear of mud-slinging (mostly). Which is good, since there’s more than enough of that in the U.S. these days, thanks to the Donald.
For those who have followed the CRISPR patent battle closely, there’s plenty to read, a good deal of it conjecture about which side, Doudna/Charpentier or Zhang, deserves what will certainly be a massive, career-altering license.
But for many who have only heard snippets (pun intended) of information, you might wonder exactly what the CRISPR-Cas9 technology is, its potential, and how the patent battle emerged in the first place.
Andy Warner of the Nib recently published a fantastic comic, “Bad Blood,” that explains the basics of CRISPR and the patent debate in 45 crisply-worded panels. I’ve included two of them here as a teaser (with permission) and urge you to take the three-minute tour of the full comic.
Our regular feature, Right Turn, appears every Friday and we invite you to submit your own blog to info(at)ccrm.ca. We encourage you to be creative and use the right (!) side of your brain. We dare you to make us laugh! Right Turn features cartoons, photos, videos and other content to amuse, educate and encourage discussion.
As always, we welcome your feedback in the comment section.
Latest posts by Lisa Willemse (see all)
- Right Turn: These three videos show why we should be impressed by our young stem cell researchers - November 18, 2016
- Right Turn: “Comic” twist on CRISPR - September 30, 2016
- Stem cells as the road to repairing Multiple Sclerosis - June 2, 2015